Literature DB >> 18723985

Does acute promyelocytic leukemia in Indian patients have biology different from the West?

Pankhi Dutta1, Sudha Sazawal, Rajat Kumar, Renu Saxena.   

Abstract

Acute promyelocytic leukemia (APML) is a well-characterized malignancy with typical clinico-hematological and molecular features. However, Indian data on this malignancy are limited. This study was conducted to determine the clinico-hematological profile of APML in India. Thirty-five patients with APML presenting to Hematology Department, AIIMS, New Delhi, between July 2003 and June 2005 were evaluated for presenting clinical features, hemogram, peripheral smear, bone marrow morphology and cytochemistry. Reverse transcriptase PCR (RT-PCR) for PML-RARalpha was done in all cases. Male-to-female ratio was 0.9:1 (males--17 and females--18) with median age 25 years (range 11-57 years). Presenting features included anemia, bleeding, fever, gum hypertrophy and scrotal ulceration. All cases showed hypergranular abnormal promyelocytes. Median hemoglobin was 6.3 g/dL (range - 3.0-9.0 g/dL), total leukocyte count (TLC) was 33.88 x 10(9) /L (range - 1-170 x 10(9) /L). Platelet count was 28 x 10(9) /L (range - 4-170 x 10(9) /L). All cases were positive for myeloperoxidase and sudan black (SB), whereas 60% cases also showed non specific esterase (NSE) positivity with 40% cases being fluoride sensitive. RT-PCR showed PML-RARalpha in 33/35 cases with the bcr3 isoform being present in 24/33 positive cases (72.7%). The two cases negative for PML-RARalpha showed typical morphology and responded to ATRA. On statistical analysis, no correlation was found between bcr isoform and TLC, platelet count, age sex and early death. Unusual features included gum hypertrophy and scrotal ulceration at presentation and high median presenting TLC (33.8 x 10(9) /L). There was, however, no microgranular variant. Another interesting feature was a high incidence of NSE positivity (60%), which was fluoride sensitive in 40%. Moreover, the bcr3 isoform was significantly overexpressed (72.7%) in comparison to other studies. APML in India has certain unusual features, which may reflect a different biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723985     DOI: 10.4103/0377-4929.42555

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  4 in total

1.  Acute promyelocytic leukaemia: looking through 'gums'.

Authors:  Ankur Jain; Deepesh Lad; Pankaj Malhotra; Karthik Bommannan
Journal:  BMJ Case Rep       Date:  2016-11-30

2.  Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up.

Authors:  Balendu Prakash; Purvish M Parikh; Sanjoy K Pal
Journal:  J Ayurveda Integr Med       Date:  2010-07

3.  Distribution of Different PML/RARα bcr Isoforms in Indian Acute Promyelocytic Leukemia (APL) Patients and Clinicohematological Correlation.

Authors:  Tathagata Chatterjee; Srishti Gupta; Sanjeevan Sharma; Prosenjit Ganguli
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-01-02       Impact factor: 2.576

4.  Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India.

Authors:  Nikhil Rabade; Goutham Raval; Shruti Chaudhary; P G Subramanian; Rohan Kodgule; Swapnali Joshi; Prashant Tembhare; Syed K Hasan; Hasmukh Jain; Manju Sengar; Gaurav Narula; Shripad Banavali; Pratibha Amare Kadam; Dhanalaxmi Shetty; Sumeet Gujral; Nikhil Patkar
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.